The detection of SF mutations demonstrates the importance of splicing abnormalities in the hematopoiesis of MDS and AML patients given the fact that abnormal splicing regulates the function of several transcriptional factors (PU.1, RUNX1, etc.)crucial in hematopoietic function. The gene discussed is RUNX1; the disease is myelodysplastic syndrome.